[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors
- 30 April 2003
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 30 (3) , 317-326
- https://doi.org/10.1016/s0969-8051(02)00442-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO)Nuclear Medicine and Biology, 2002
- Cellular accumulation and retention of the technetium-99m-labelled hypoxia markers BRU59-21 and butylene amine oximeNuclear Medicine and Biology, 2001
- Tumoroxygenierung und HypoxieDer Onkologe, 1999
- Quantifying Hypoxia with Radiolabeled Fluoromisonidazole: Pre-Clinical and Clinical StudiesPublished by Springer Nature ,1999
- Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Nitroimidazoles and imaging hypoxiaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Imaging of hypoxia in human tumors with [F-18]fluoromisonidazoleInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Tumor tissue oxygenation as evaluated by computerized-po2-histographyInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: Potential in vivo markers of hypoxic tissueApplied Radiation and Isotopes, 1986
- Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing dataInternational Journal of Radiation Oncology*Biology*Physics, 1984